Clinical trial
The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in…
NCT00315874 · Purdue Pharma LP, Industry · Completed
Key facts
| NCT number | NCT00315874 |
|---|---|
| Title | The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. |
| Official title | Safety and Efficacy of Buprenorphine TDS (Transdermal Delivery System) 5, 10 and 20 Applied Every 7 Days for Sixty Days vs. 5 mg Oxycodone/325 mg Acetaminophen Tablets q6h Prn vs. Placebo in Patients With Chronic Low Back Pain |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Back Pain |
| Intervention type | Drug |
| Interventions | Buprenorphine transdermal delivery system |
| Enrollment | 225 |
| Start date | Apr 1, 1997 |
| Completion | Jan 1, 1998 |
| First posted | Apr 19, 2006 |
| Last update posted | May 14, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: